ANTIGEN-COUPLED IMMUNOREAGENTS
The present disclosure provides high-performance immunoreagents for use in a variety of immunologic assays and other related techniques. The immunoreagents comprise a primary antibody and a bridging antigen, wherein the bridging antigen is recognized by a detectable secondary antibody with high affinity. Also provided are compositions comprising panels of immunoreagents specific for multiple different target antigens and compositions comprising pairs of primary immunoreagents and their complementary detectable secondary antibodies. The paired primary immunoreagents and secondary antibodies are useful in a variety of immunologic assays, particularly in highly multiplexed assays, where the structure of the bridging antigen is varied in tandem with variation in the detectable secondary antibody, such that a multiplicity of immunoreagents are provided that are capable of simultaneously detecting a multiplicity of target antigens in a single assay. Also provided are kits comprising the immunoreagents, methods of immunologic assay using the immunoreagents of the disclosure, and methods of preparation of the immunoreagents.
1 - 122 . (canceled)
123 . An immunoreagent composition comprising a primary antibody coupled to a bridging antigen, and a detectable secondary antibody,
wherein the bridging antigen comprises a peptide;
wherein the peptide comprises:
at least one charged amino acid,
at least one hydrophobic amino acid, and
at least one polar uncharged amino acid.
124 . The immunoreagent composition of claim 123 , wherein the peptide comprises a non-natural residue.
125 . The immunoreagent composition of claim 123 , wherein the peptide comprises a branched structure or a tandem repeat.
126 . The immunoreagent composition of claim 123 , wherein the peptide comprises at least four amino acids.
127 . The immunoreagent composition of claim 123 , wherein at least three amino acids are charged amino acids.
128 . The immunoreagent composition of claim 123 , wherein at least two amino acids are hydrophobic amino acids.
129 . The immunoreagent composition of claim 123 , wherein the peptide is expressed as part of the primary antibody.
130 . The immunoreagent composition of claim 123 , wherein the detectable secondary antibody is a monoclonal antibody specific for the peptide and having a dissociation constant of at most 10 nM.
131 . The immunoreagent composition of claim 123 , wherein the bridging antigen substitutes functionality for cross-species recognition of the primary antibody by the detectable secondary antibody.
132 . A multiplexed immunoreagent composition comprising a plurality of immunoreagent pairs;
wherein each pair comprises a bridging antigen comprising a peptide, and a corresponding secondary antibody;
wherein each pair is different;
wherein the corresponding secondary antibody binds with high affinity to the peptide; and
wherein the peptide comprises:
at least one charged amino acid,
at least one hydrophobic amino acid, and
at least one polar uncharged amino acid.
133 . The multiplexed immunoreagent composition of claim 132 , wherein the peptide comprises at least one charged amino acid, at least one hydrophobic amino acid, at least one polar uncharged amino acid, and at least one of a proline or a glycine.
134 . The multiplexed immunoreagent composition of claim 133 , wherein the peptide comprises a non-natural residue.
135 . The multiplexed immunoreagent composition of claim 133 , wherein the peptide comprises a branched structure.
136 . The multiplexed immunoreagent composition of claim 133 , wherein the peptide comprises at least four amino acids.
137 . The multiplexed immunoreagent composition of claim 133 , wherein the peptide comprises at least three charged amino acids.
138 . The multiplexed immunoreagent composition of claim 133 , wherein the peptide comprises at least two hydrophobic amino acids.
139 . The multiplexed immunoreagent composition of claim 133 , wherein the bridging antigen substitutes functionality for cross-species recognition of a primary antibody by the corresponding secondary antibody.
140 . The multiplexed immunoreagent composition of claim 133 , comprising at least three pairs.
141 . The multiplexed immunoreagent composition of claim 133 , wherein said corresponding secondary antibody is a monoclonal antibody specific for the peptide and having a dissociation constant of at most 10 nM.